Adheris Health Limited (AU:AHE) — Market Cap & Net Worth

$136.67 USD  · AU$193.16 AUD  · Rank #31480

Market Cap & Net Worth: Adheris Health Limited (AHE)

Adheris Health Limited (AU:AHE) has a market capitalization of $136.67 (AU$193.16) as of May 2, 2026. Listed on the AU stock exchange, this Australia-based company holds position #31480 globally and #1837 in its home market, demonstrating a 0.00% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Adheris Health Limited's stock price AU$0.02 by its total outstanding shares 9658 (9.66K). Analyse AHE cash flow metrics to see how efficiently the company converts income to cash.

Adheris Health Limited Market Cap History: 2026 to 2026

Adheris Health Limited's market capitalization history from 2026 to 2026. Data shows growth from $136.67 to $136.67 (0.00% CAGR).

Adheris Health Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Adheris Health Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
No financial ratio data available

Competitor Companies of AHE by Market Capitalization

Companies near Adheris Health Limited in the global market cap rankings as of May 2, 2026.

Key companies related to Adheris Health Limited by market ranking:

  • Veeva Systems Inc Class A (NYSE:VEEV): Ranked #926 globally with a market cap of $28.21 Billion USD.
  • Pro Medicus Ltd (AU:PME): Ranked #2225 globally with a market cap of $10.06 Billion USD ( AU$14.22 Billion AUD).
  • Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2339 globally with a market cap of $9.34 Billion USD.
  • BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2447 globally with a market cap of $8.82 Billion USD.
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#926 Veeva Systems Inc Class A NYSE:VEEV $28.21 Billion $171.60
#2225 Pro Medicus Ltd AU:PME $10.06 Billion AU$136.16
#2339 Tempus AI, Inc. Class A Common Stock NASDAQ:TEM $9.34 Billion $55.00
#2447 BrightSpring Health Services, Inc. Common Stock NASDAQ:BTSG $8.82 Billion $52.58

Adheris Health Limited Historical Marketcap From 2026 to 2026

Between 2026 and today, Adheris Health Limited's market cap moved from $136.67 to $ 136.67, with a yearly change of 0.00%.

Year Market Cap Change (%)
2026 AU$136.67 --

End of Day Market Cap According to Different Sources

On May 2nd, 2026 the market cap of Adheris Health Limited was reported to be:

Source Market Cap
Yahoo Finance $136.67 USD
MoneyControl $136.67 USD
MarketWatch $136.67 USD
marketcap.company $136.67 USD
Reuters $136.67 USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Adheris Health Limited

AU:AHE Australia Health Information Services
Market Cap
$136.67
AU$193.16 AUD
Market Cap Rank
#31480 Global
#1837 in Australia
Share Price
AU$0.02
Change (1 day)
-4.76%
52-Week Range
AU$0.02 - AU$0.02
All Time High
AU$0.02
About

Adheris Health Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, the United States, and the United Kingdom. The company offers THRiV, an omni-channel platform which provides pharmacy-driven patient and pharmacist engagement solutions to improve medication management. The company was formerly known as MedAdvisor Limited and changed its anm… Read more